11.02.2026 21:33
👍 1
🔁 0
💬 0
📌 0
Celebrating some of the brilliant women in our team and the trailblazers who inspire them this International Day of Women and Girls in Science 👩🔬✨
Scroll through below ⬇️⬇️
#WomenInScience #InternationalDayOfWomenAndGirlsInScience
Aglaia Skolariki, 2nd year Clinical Research Training Fellow, is researching how abnormal cell division in aggressive cancers drives particular genetic changes. 👇#InternationalDayofWomenAndGirlsInScience2026
@medsci.ox.ac.uk @oncology.ox.ac.uk @oxcio.bsky.social
www.cancer.ox.ac.uk/news/interna...
Our second annual Oesophagogastric Cancer Centre of Excellence Symposium will examine how recent advancements in research and clinical practice are contributing to improved patient outcomes.
✅Open to @ox.ac.uk researchers
📆March 6th, 9am to 5pm
Register 👇
www.eventbrite.co.uk/e/oesophagog...
Eric O'Neill is part of a £15.9m project to transform cancer research using live human tissue models.
"We will be able to test therapies on patients’ own tumours before they are prescribed a therapy. This will allow us to figure out what treatment is most likely to work for each patient"
Geoff Higgins leads on National Cancer Imaging Translational Accelerator (NCITA), a UK-wide medical imaging infrastructure which aims to accelerate the standardisation & translation of cancer imaging biomarkers for clinical use.
www.nature.com/articles/s41...
Kate Vallis focuses on therapeutic radionuclides in solid tumours.
Her team are developing strategies to predict tumour response to radionuclide therapy, to enable individualised dosing instead of using a one-size-fits-all approach.
www.oncology.ox.ac.uk/research/res...
Anna Schuh & her team are developing liquid biopsies to detect blood cancer early, stratify risk & monitor treatment response.
By analysing circulating tumour DNA, these tests can guide treatment decisions, helping clinicians know when to switch/stop therapy.
www.oncology.ox.ac.uk/research/res...
Every cancer is different. Every patient is unique.
On #WorldCancerDay2026, meet the researchers helping shape more individualised cancer care.
#UnitedByUnique
#ScientistSpotlight 🧪
This week we’re featuring Robert Watson, an Academic Clinical Lecturer in the Department of Oncology, University of Oxford.
@ox.ac.uk @oncology.ox.ac.uk @medsci.ox.ac.uk
🆕Study launched to investigate whether insulin levels influence how women with the most common type of breast cancer respond to treatment.
Trans-EndoNET will examine the relationship between insulin levels & response to aromatise inhibitors in women with ER+HER2- breast cancer.
The LFS UK 2025 conference took place last September, updating on studies from across the country, including MILI.
Visit LFS UK 2025 to see the various presentations and update on the MILI trial tinyurl.com/d2dfm36x
#TP53 #LiFraumeniSyndrome #LFS @oncology.ox.ac.uk @oxfordcancer.bsky.social
Researchers from the Jiang Group have published Phase Ia trial results for OVM-200, a novel cancer vaccine targeting survivin.
The first-in-human trial, published in eClinicalMedicine, reports promising early safety & immunogenicity findings in patients with advanced solid tumours.
buff.ly/ZLCqaGC
The Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Funding Scheme is open!
🔎Pump-priming cancer early detection and prevention research
🧪Open to @ox.ac.uk researchers
💷£20K 1-year awards
📆Deadline: Fri 27 Feb
More on the OxCODE website 👇
www.oxcode.ox.ac.uk/about/oxcode....
2025 in numbers.
A year of research, teaching, and collaboration.
TrustedMDT will be piloted at Oxford University Hospitals NHS Foundation Trust, marking one of the first deployments of agentic AI within a clinically-realistic tumour board setting.
Find out more about the pilot study: www.oncology.ox.ac.uk/research/pro...
TrustedMDT is a multi-agent AI system designed to support cancer treatment planning.
The tool is made up of three agents, integrated into Microsoft teams, that work in concert to summarise clinical records, determine disease stage & draft evidence-based treatment recommendations.
@medsci.ox.ac.uk
Parkes lab pre-print alert! ‘TMEM33 deletion potentiates anti-tumor CD8⁺ T cell immunity.’ Led by mtjackson101.bsky.social. Full bluetutorial follows! 1/10 www.biorxiv.org/content/10.6...
New Vacancy: Postdoctoral Researcher in Bioinformatics & Human Tissue Modelling
We have an exciting opportunity to join the O'Neill lab, contributing to a pioneering tissue-focused research programme aimed at enhancing cure rates for gastrointestinal cancers.
www.oncology.ox.ac.uk/about-us/wor...
NEW: Oxford researchers have developed TrustedMDT, a multi-agent artificial intelligence (AI) system designed to support medical specialists during cancer treatment planning meetings.
Find out more ⬇️
Congratulations to Kendra Perez-Smith, Translational Support Unit Manager, who has received an Outstanding Contribution to Sustainability Award for her innovation & leadership in establishing Lab QuTe: a department-wide network designed to reduce the environmental impact of clinical trials.
Researchers at @oncology.ox.ac.uk have developed TrustedMDT, a multi-agent AI system designed to support cancer treatment planning.
TrustedMDT is made up of three AI agents that work in concert to summarise clinical records, determine disease stage & draft treatment recommendations.
Read more ⬇️
Congratulations to Keaton Jones who has received a @wellcometrust.bsky.social Early Career Award 🔬
The funding will enable Keaton & his team to shed light on immunotherapy resistance in pancreatic cancer, a critical hurdle that, if overcome, could provide much needed new treatment options.
Congratulations to the team at Brighton and Sussex for recruiting 61 participants to SCOOT. @uhsussex.bsky.social @chestconsultant.bsky.social @oncology.ox.ac.uk
#lungcancer #personalisedtherapy and #earlydiagnosis
In case you missed it!
Sarah Blagden @oncology.ox.ac.uk featured in Channel 4’s Cancer Detectives: Finding the Cures last week, sharing ground-breaking precision-prevention research at Oxford!
Read more ⬇️
@sarahblagden.bsky.social @medsci.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Oxford Professor Sarah Blagden, @oncology.ox.ac.uk appears in the first episode of Cancer Detectives: Finding the Cures on @Channel4 tonight!
📺 Watch at 9pm, Thurs 20 Nov, or stream on Channel 4.
Brought to you by @CR_UK.
#CancerDetectives #CancerPrevention
www.channel4.com/programmes/c...
We’re thrilled to partner with Channel 4 on ‘Cancer Detectives: Finding the Cures’ - a new series which is shining a light on three trailblazing scientists taking on cancer, and explores how their work is changing patients’ lives right now. 👇 1/2
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
People at high risk of lung cancer will soon be able to receive the experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial.
@medsci.ox.ac.uk @oxfordcancer.bsky.social
Next up in the Meet The MILI Team series, is Dr Schaida Schirwani.
Dr Schirwani is a genetics consultant and is part of the MILI team at University Hospital Southampton.
#LFS #LiFraumeni @uhsft.bsky.social @oncology.ox.ac.uk
@oxfordcancer.bsky.social
tp53.co.uk/lfs-tp53/
What if we could stop #Cancer before it even starts?
Prof. Sarah Blagden @oncology.ox.ac.uk & PPI contributor Anna Fry discuss novel cancer prevention research on the @oxfordsparks.bsky.social podcast.
🎧 www.oxfordsparks.ox.ac.uk/podcasts/cou...
@sarahblagden.bsky.social @medsci.ox.ac.uk
